Pharmaceuticals Market Research Reports
Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
... and Trends for April 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” ... manner. Find out the major deal performing segments for investments in your industry. Evaluate the types of companies which are entering ...
May, 2013 68 pages... Reimbursement Landscape - Italy Summary GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement ...
May, 2013 299 pages... specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and ... covers both the pharmaceutical and the medical devices markets of France. The report will enhance your decision making capability. It will ...
May, 2013 248 pages... 2013 Summary GBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and ... The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and strategic ...
May, 2013 67 pages... disease, central and peripheral nervous system, and immunology. Sigma-Tau operates three research centers in Italy, the UK and Switzerland, and manages two production facilities in the US and Spain. GlobalData’s Sigma-Tau S.p.A. - Strategic SWOT Analysis Review provides a ...
May, 2013 25 pages... Reports Revenue Of $397.3m In Q1 2012 Feb 16, 2012: Res-Care Reports Revenue Of $1.6 Billion In 2011 GlobalData’s Res-Care, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed ...
May, 2013 22 pages... Trofile, Trofile DNA, PhenoSense GT, PhenoSense HIV, GenoSure MG, PhenoSense Entry, PhenoSense Integrase and Replication Capacity. GlobalData’s Monogram Biosciences, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and ...
May, 2013 25 pages... Case Western Reserve Researchers Discover Bexarotene Rapidly Clears Amyloid From Brain And Reverses Cognitive Defects This comprehensive SWOT profile of Ligand Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...
May, 2013 46 pagesSummary Karo Bio AB (Karo Bio) is a pharmaceutical company. It discovers and develops therapeutic products for inflammation, cancer, neuropsychiatry, autoimmune diseases and women's health. The company develops new pharmaceuticals based on the nuclear receptors as target protein. The product portfolio of ...
May, 2013 41 pages... Hyperion Therapeutics Reports Q3 2012 Results Sep 06, 2012: Hyperion Therapeutics Reports Q2 2012 Results This comprehensive SWOT profile of Hyperion Therapeutics, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to ...
May, 2013 35 pages... others. It also develops, marketed and sold Coreg CR using Micropump technology. It secures patents and other intellectual property rights over its ... Announces FDA Acceptance Of New Drug Application Jul 25, 2012: Flamel Technologies Reports Total Revenue Of $6.1m For Q2 2012 This comprehensive SWOT profile ...
May, 2013 39 pages... Key Recent Developments Jun 08, 2012: CLC bio Delivers Specialized Antibody Engineering And Selection Software For Crucelln GlobalData’s Crucell N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The ...
May, 2013 28 pages... UK Aug 01, 2012: Clinova Launches ORS In UK Jan 10, 2012: Clinova Receives Patent For Stemaderm GlobalData’s Clinova Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT ...
May, 2013 21 pages... : MediSapiens To Provide Bayer With New Cloud Computing Application To Analyze And Visualize Multi-Dimensional Genomics Datan GlobalData’s Bayer HealthCare Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and ...
May, 2013 26 pages... Inc. Key Recent Developments May 07, 2012: Ardea Biosciences Reports Revenue Of $1.5m In Q1 2012 Mar 09, 2012: Ardea Biosciences Reports Revenue Of $1.7m In Q4 2011 GlobalData’s Ardea Biosciences, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate ...
May, 2013 25 pages... the EMEA region, and the APAC region; it also covers the Global Medication Management System market landscape and its growth prospects in the coming years. The ... ., and Webster Care Key questions answered in this report: What will the market size be in 2016 and at what will be the growth rate? What are key ...
May, 2013 46 pages... to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022 ... , with the potential of providing higher efficacy without sacrificing safety. Tcelna was developed by Opexa Therapeutics, which has recently entered into ...
Mar, 2013 60 pages... to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. ... following the patent expiries of key branded products during the forecast period. In addition, the entry of new companies such as Sanofi/Genzyme ...
Mar, 2013 61 pagesOpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it occurs primarily in older adults’ =50 years old, with an ...
Apr, 2013 136 pagesOpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic ...
Apr, 2013 137 pages
